Special Edition - Getting Real about COVID-19 Data Part 1: A conversation with Amy Abernethy

BioCentury This Week

English - May 08, 2020 21:00 - 21 minutes - 15 MB - ★★★★★ - 11 ratings
Science biotech biopharma pharmaceutical research investment dealmaking Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Special Edition - Consummating a deal under lockdown

Next Episode: Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19

Amy Abernethy, FDA’s principal deputy commissioner and acting CIO describe in podcast interview with BioCentury’s Washington Editor Steve Usdin how the pandemic has accelerated progress on integrating real-world data and evidence into research and practice.